These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 16640959)
1. Oxidized lipids: the two faces of vascular inflammation. Birukov KG Curr Atheroscler Rep; 2006 May; 8(3):223-31. PubMed ID: 16640959 [TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature. Navab M; Reddy ST; Van Lenten BJ; Buga GM; Hough G; Wagner AC; Fogelman AM Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2553-60. PubMed ID: 23077141 [TBL] [Abstract][Full Text] [Related]
3. How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses. Rhoads JP; Major AS Crit Rev Immunol; 2018; 38(4):333-342. PubMed ID: 30806246 [TBL] [Abstract][Full Text] [Related]
4. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Nakajima K; Nakano T; Tanaka A Clin Chim Acta; 2006 May; 367(1-2):36-47. PubMed ID: 16448638 [TBL] [Abstract][Full Text] [Related]
6. Oxidized Phospholipids in Healthy and Diseased Lung Endothelium. Karki P; Birukov KG Cells; 2020 Apr; 9(4):. PubMed ID: 32326516 [TBL] [Abstract][Full Text] [Related]
7. α-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol. Abu-Fanne R; Maraga E; Abd-Elrahman I; Hankin A; Blum G; Abdeen S; Hijazi N; Cines DB; Higazi AA J Biol Chem; 2016 Feb; 291(6):2777-86. PubMed ID: 26518877 [TBL] [Abstract][Full Text] [Related]
8. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Leonarduzzi G; Gamba P; Gargiulo S; Biasi F; Poli G Free Radic Biol Med; 2012 Jan; 52(1):19-34. PubMed ID: 22037514 [TBL] [Abstract][Full Text] [Related]
9. Postprandial lipoproteins and the molecular regulation of vascular homeostasis. Botham KM; Wheeler-Jones CP Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety Lu J; Guo S; Xue X; Chen Q; Ge J; Zhuo Y; Zhong H; Chen B; Zhao M; Han W; Suzuki T; Zhu M; Xia L; Schneider C; Blackwell TS; Porter NA; Zheng L; Tsimikas S; Yin H J Biol Chem; 2017 Mar; 292(13):5378-5391. PubMed ID: 28202546 [TBL] [Abstract][Full Text] [Related]
11. Lipid mediators in the regulation of endothelial barriers. Karki P; Birukov KG Tissue Barriers; 2018 Jan; 6(1):e1385573. PubMed ID: 29083949 [TBL] [Abstract][Full Text] [Related]
12. An update on lipid oxidation and inflammation in cardiovascular diseases. Zhong S; Li L; Shen X; Li Q; Xu W; Wang X; Tao Y; Yin H Free Radic Biol Med; 2019 Nov; 144():266-278. PubMed ID: 30946962 [TBL] [Abstract][Full Text] [Related]
15. The associations of oxidized high-density lipoprotein lipids with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. Kresanov P; Ahotupa M; Vasankari T; Kaikkonen J; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT Free Radic Biol Med; 2013 Dec; 65():1284-1290. PubMed ID: 24095850 [TBL] [Abstract][Full Text] [Related]